Turkish Journal of Biology
Volume 41

Number 2

Article 8

1-1-2017

Biocompatible polymeric coatings do not inherently reducethe
cytotoxicity of iron oxide nanoparticles
AYLİN ŞENDEMİR ÜRKMEZ
ECE BAYIR
EYÜP BİLGİ
MEHMET ÖZGÜN ÖZEN

Follow this and additional works at: https://journals.tubitak.gov.tr/biology
Part of the Biology Commons

Recommended Citation
ÜRKMEZ, AYLİN ŞENDEMİR; BAYIR, ECE; BİLGİ, EYÜP; and ÖZEN, MEHMET ÖZGÜN (2017) "Biocompatible
polymeric coatings do not inherently reducethe cytotoxicity of iron oxide nanoparticles," Turkish Journal
of Biology: Vol. 41: No. 2, Article 8. https://doi.org/10.3906/biy-1608-61
Available at: https://journals.tubitak.gov.tr/biology/vol41/iss2/8

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Biology by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Biology

Turk J Biol
(2017) 41: 322-332
© TÜBİTAK
doi:10.3906/biy-1608-61

http://journals.tubitak.gov.tr/biology/

Research Article

Biocompatible polymeric coatings do not inherently reduce
the cytotoxicity of iron oxide nanoparticles
1,2,3,

2,3

1

4

Aylin ŞENDEMİR ÜRKMEZ
*, Ece BAYIR , Eyüp BİLGİ , Mehmet Özgün ÖZEN
1
Department of Bioengineering, Faculty of Engineering, Ege University, İzmir, Turkey
2
Department of Biomedical Technologies, Graduate School of Natural and Applied Sciences, Ege University, İzmir, Turkey
3
Application and Research Center for Testing and Analysis (EGE-MATAL), Ege University, İzmir, Turkey
4
Bio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Department of Radiology, Canary Center at Stanford for Cancer Early
Detection, Stanford University, Palo Alto, CA, USA
Received: 22.08.2016

Accepted/Published Online: 07.12.2016

Final Version: 20.04.2017

Abstract: Nanotechnology in biomedical research is an emerging and promising tool for different purposes, like high-resolution medical
imaging, diagnostics, and targeted drug delivery. Although some experimental efforts focused on determination of the cytotoxicity of
nanoparticles (NPs) are present, there are many controversial results. In this study, chitosan (CS)- and poly(acrylic acid) (PAA)-coated
iron oxide nanoparticles (IONPs) were used to investigate the possible cytotoxicity of coated IONPs on model mammalian cell line
SaOs-2 by evaluating cellular viability and membrane integrity. Increasing concentrations of IONPs increased the cytotoxic effect on
SaOs-2 cells with both CS- and PAA-coated IONPs. Cell viability on day 3 was as low as 40% and 48% at 1000 µM concentration for PAAand CS-coated IONPs, respectively, in 1% FBS-supplemented media. Cytotoxicity determined by the released lactate dehydrogenase
(LDH) was as high as 163% with 1000 µM concentration of CS-IONPs, while there was no significant change in LDH release with PAAcoated IONPs at any concentration. This study reveals that IONPs coated with a biocompatible polymer, which are usually assumed
to be nontoxic, show cytotoxicity with increasing concentration and incubation time. The cytotoxicity of nanoparticles intended for
biomedical purposes must be evaluated using more than one approach.
Key words: Iron oxide nanoparticles, poly(acrylic acid), chitosan, human osteoblast-like cell line, cytotoxicity

1. Introduction
Magnetic nanoparticles (MNPs) are nanoscale materials
(1–100 nm) and they commonly consist of magnetic
elements such as iron, nickel, or cobalt and their chemical
compounds. Their unique physical, chemical, electrical,
thermal, and magnetic properties offer many potential
uses in various fields, such as physics, medicine, biology,
and materials science (Li et al., 2008; Bao et al., 2016).
Because of the toxicity of nickel and cobalt elements,
iron-based nanoparticles are more commonly used for
biomedical applications (Mahmoudi et al., 2011b). In
the last few decades, MNPs have been increasingly used
in biomedicine, especially for drug delivery, magnetic
resonance imaging, hyperthermia therapy, biosensors,
theranostic devices, cell sorting, cell labeling, tissue repair,
and magnetofection studies (Gupta and Gupta, 2005;
Kaushik et al., 2008; Mahdavi et al., 2013; Bayir et al., 2014;
Gudovan et al., 2015).
Iron oxide nanoparticles (IONPs) often agglomerate
due to their physicochemical properties (Li et al., 2008;
* Correspondence: aylin.sendemir@ege.edu.tr
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Wahajuddin, 2012). IONPs can be coated by various suitable
molecules in order to prevent the formation of iron oxide
clusters. Although IONPs are relatively biocompatible,
many coating materials such as poly(ethylene glycol),
dextran, heparin, silica, and phospholipids are used in
order to prevent the generation of reactive oxygen species
(ROS) and improve their biocompatibility for in vivo and
in vitro applications (Mikhaylova et al., 2004; Fang and
Zhang, 2009; Ling and Hyeon, 2013).
Tumor cell lines, due to their easy handling in vitro and
highly proliferative capacity, have been utilized frequently
for the investigation of various tumor cell biology
characteristics, as well as mechanisms of carcinogenesis
(Susa et al., 2009). In this study, a human osteosarcomaderived cell line, SaOs-2, was used as a model cell line to
test polymer-coated IONPs’ cytotoxicity. Osteosarcoma is
the most common bone cancer with an overall survival rate
of <20%, predominantly seen in children and adolescents
(Mohseny et al., 2011; Lauvrak et al., 2013).
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Synthetic and natural polymers are widely used in the
biomedical field for different purposes. In this study, IONPs
were coated by both a synthetic polymer (poly(acrylic
acid): PAA) and a natural polymer (chitosan: CS) to
investigate the effects of different concentrations of coated
IONPs on in vitro cultures of human osteoblast-like cells
(SaOs-2). CS is an attractive biopolymer for biomedical
applications because chitin, which is the natural source
of CS, is the second-most abundant polysaccharide on
earth after cellulose and it is highly biocompatible and
biodegradable by human enzymes (Bhattarai et al., 2010).
Fibrous CS scaffolds, in a biomineralized form, have high
biocompatibility with SaOs-2 cells, allow cell attachment
and extracellular matrix formation, and cause very low
(<10%) apoptotic or necrotic effect on these cells (Ucar et
al., 2016). CS is particularly attractive for drug conjugates
and targeted delivery applications (particularly for anionic
drugs), since its chemistry allows it to be easily modified
and functionalized in order to incorporate specificity
and selectivity. CS-conjugated NPs were recently shown
to target osteosarcoma (SaOs-2) cells in vitro effectively
through cancer-specific integrin receptors (Mansur et al.,
2016). CS-based NPs, as carriers for ursolic acid (Zhang et
al., 2015) and retinoic acid (Qin et al., 2015), were shown
to inhibit proliferation of osteosarcoma (SaOs-2, U2OS,
and MG-63) cells due to a decrease in membrane potential
and release of cytochrome C as well as cell cycle arrest. CS
was also used for encapsulation and slow release of c-jun
(an oncogene) DNAzymes to induce apoptotic cell death
in SaOs-2 cells (Dass et al., 2008).
These properties make CS a good candidate for coating
IONPs. Even though CS is a biocompatible polymer,
an additional modification of CS is needed to make
water-soluble composites (Li et al., 2012). Thus, another
biocompatible biopolymer, PAA (Tripathi et al., 2016), was
chosen to make the IONPs both biocompatible and well
dispersed in culture medium without additional chemical
treatment. PAA is a well-characterized weak polyanion.
Besides its water solubility, PAA is FDA-approved as an
inactive ingredient (as a stabilizer and thickener to tune
rheological properties) in drug formulations, and it is
used clinically for oral, mucosal, and even ocular delivery
of drugs due to its safety in pharmaceutical applications
(Kadajji and Betageri, 2011; Morton et al., 2014). PAA,
in a side-chain functionalized form with alendronate
(a clinically used bisphosphonate), binds and is rapidly
internalized by human osteosarcoma (143B) cells (Morton
et al., 2014).
Currently, no universally accepted procedure to
investigate the cytotoxicity of NPs is available. Cytotoxicity
evaluation of NPs by a single analysis method can lead to
false negative or false positive results due to the fact that
NPs can affect animal cells via different pathways, e.g., the

destruction of the membrane structure or the changing
of the mechanism of the intracellular pathway. Cell–
nanoparticle interaction is a dynamic and complicated
process, which includes several known and unknown
parameters, such as interactions of nanoparticles with the
cell membrane, culture media components, cytoplasmic
fluids, or DNA as well as interactions between the culture
media components and coating materials. It has been
shown that naked IONPs could lead to cytotoxicity in
animal cells above a certain concentration (Hussain et
al., 2005; Ankamwar et al., 2010; Soenen et al., 2011).
Therefore, it is a common practice to coat IONPs with
biocompatible polymers to reduce their cytotoxicity (Mura
et al., 2011; Bahring et al., 2013; Grabowski et al., 2015).
In this study, it is hypothesized that IONPs can be
cytotoxic even after being coated by biopolymers that are
assumed to be biocompatible. Therefore, cytotoxicity of
IONPs must be examined via different analysis methods
if they are intended for use in medical procedures.
The hypothesis was tested by investigation of the
biocompatibility of CS- and PAA-coated IONPs (CSIONPs and PAA-IONPs, respectively) in vitro and by
comparing the results of two different cytotoxicity assays,
lactate dehydrogenase (LDH) and [3-(4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium bromide] (MTT).
2. Materials and methods
In order to determine the cytotoxic effects of CS- and PAAIONPs on the SaOs-2 cell line, the cells were subjected
to various concentrations of IONPs (10, 100, and 1000
µM) for 24 and 72 h. Two different analysis methods,
MTT and LDH, were used for determining cytotoxicity.
Since serum proteins affect the results, the assay medium
must include 1% serum for LDH analysis. MTT was also
examined with 1% serum-containing media in addition
to the standard serum concentration (10%) to compare
the results properly. The morphology of the cells and the
dispersion of the IONPs were observed with inverted
microscopy, scanning electron microscopy (SEM), and
energy-dispersive X-ray spectroscopy (EDX) techniques.
Independent variables in the experimental design were
the concentration of the IONPs, the coating materials, and
IONP exposure time. Dependent variables were the cell
viability and membrane integrity.
2.1. Cell culture
The SaOs-2 cell line was obtained from HUKUK
(Culture Collection of Animal Cells, Foot and Mouth
Disease Institute, Ankara, Turkey). The cells were used
between passages 5 and 10 and were cultured at 37 °C
in an atmosphere of 5% CO2 in a humidified incubator.
The culture medium was Dulbecco’s modified Eagle’s
medium with Ham’s F-12 (1:1) (HyClone DMEM/F-12;
GE Healthcare Lifesciences, Marlborough, MA, USA)
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supplemented with 10% (v/v) fetal bovine serum (FBS;
Biochrom, Berlin, Germany) and 100 U/mL penicillin and
100 µg/mL streptomycin (Biochrom). The culture medium
was replaced with fresh medium every 2–3 days; cells were
passaged before reaching 85% confluence, and split into
1/3 in tissue culture dishes by lifting with trypsin-EDTA
solution (0.05% trypsin, 0.02% EDTA; Sigma-Aldrich, St.
Louis, MO, USA).
2.2. Treatment of SaOs-2 cells with IONPs
CS-IONPs and PAA-IONPs were kindly provided by
Dr Serhat Küçükdermenci from the Ege University
Department of Electrical and Electronics Engineering.
Küçükdermenci et al. described the production method
and characterization results in their study (2013).
Briefly, in their polyol method, NaOH, diethylene glycol,
biopolymers, and FeCl3 were vigorously mixed at a high
temperature under nitrogen, and IONPs were obtained
after washing, sedimentation, and drying steps. The
average size of the IONPs was approximately 10 nm.
SaOs-2 cells were plated at a density of 1 × 104 cells/
well in 96-well plates (Greiner Bio-One; Frickenhausen,
Germany) for MTT (Sigma-Aldrich) and LDH cytotoxicity
(Roche; Stockholm, Sweden) assays. To determine cellular
uptake and morphological changes (if any) with SEM, the
cells were plated at a density of 2 × 105 cells/well in 12-well
plates (Greiner Bio-One) on glass coverslips. After 24 h,
cells were washed with PBS and the media were replaced
with fresh media containing PAA- and CS-IONPs in
different concentrations (10, 100, and 1000 µM). Media
were supplemented with 1% and 10% FBS for MTT assay
and 1% FBS for LDH assay. MTT and LDH assays were
performed after periods of 24 and 72 h.
2.3. MTT assay
Viability of SaOs-2 cells after exposure to IONPs was
assessed by MTT assay. After 24 and 72 h of treatment,
the culture medium was replaced with fresh, serum-free
medium containing 10% MTT solution, and the cells
were incubated for 3 h at 37 °C in 5% CO2 atmosphere
until the yellow MTT tetrazolium salt was reduced to
purple formazan crystals by mitochondrial succinate
dehydrogenase. Formazan crystals were solubilized with
dimethyl sulfoxide (DMSO; Merck, Darmstadt, Germany),
and the absorbance of each well was read on a microplate
reader (Spectramax; Molecular Devices, Sunnyvale, CA,
USA) at 570–690 nm.
2.4. LDH assay
LDH is a cytoplasmic enzyme that leaks into the culture
medium when plasma membrane integrity is disrupted.
The amount of LDH released into the culture medium is
related to cytotoxicity due to cell membrane disruption.
After 24 and 72 h of IONP exposure, the 96-well plate was
centrifuged to settle the nanoparticles and the cells in the
medium. Supernatant (50 µL) was transferred to a fresh
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well in a 96-well plate and 50 µL of serum-free medium
was added for dilution. The reaction mixture (Cytotoxicty
Detection Kit Plus (LDH), Roche) was added (100 µL) to
the supernatant and incubated for 30 min at 25 °C. After
incubation, 50 µL of stop solution was added and the
absorbance of each well was read on a microplate reader
at 490–690 nm.
2.5. Sample preparation for SEM and EDX
The samples were prepared for SEM and EDX analysis
after 3 days of IONP exposure to determine morphological
changes of cells (if any), perform elemental analysis
on cell membranes, and observe cellular IONP uptake.
Briefly, the samples were washed with PBS and then kept
in 0.1 M sodium cacodylate (Sigma-Aldrich) and 5%
(v/v) glutaraldehyde (Merck) for 30 min on ice. After
glutaraldehyde fixation, the samples were kept in 7% (w/v)
sucrose (Sigma-Aldrich) in 1 M sodium cacodylate and
in 2% (w/v) osmium tetroxide (Sigma-Aldrich) in 1 M
sodium cacodylate for periods of 30 min on ice. The cells
were then washed two times with distilled water, serially
dehydrated in ethanol at room temperature (25 °C), and
kept in hexamethyldisilazane (HMDS, Sigma-Aldrich)
solution for 5 min. After removal of the HMDS, the
samples were air-dried at room temperature. The samples
were stored in a desiccator after the completion of drying.
Before the SEM examination, samples were sputter-coated
with gold-palladium.
2.6. Statistical analysis
All values presented in this study are represented as means
± standard deviation of experiments made with five
replicates. Statistical significance was determined by oneway analysis of variance (ANOVA). Multiple comparisons
were analyzed using the Tukey post hoc method. Statistical
significance was described at P < 0.05.
3. Results
3.1. Cell culture
SaOs-2 cells show epithelial-like morphology. The
morphology of the cells and agglomeration of the CSIONPs after treatment with IONPs are shown in Figure
1. Control cells were grown in the same medium with
experimental groups but were not treated with IONPs.
PAA-IONPs cannot be seen in the images, since they
are well dispersed in the medium. This is expected,
because PAA has been used as a coating agent to control
dispersibility before (Jeong et al., 2010; Huang et al., 2014),
and the high dispersibility of PAA-IONPs in water makes
them good candidates for dispersion of the nonsoluble
nanoparticles in water-based media. Shen et al. reported
that coating Ag NPs with PAA preserves and enhances the
stability of NPs, and they called this phenomenon a “cage
effect” (Shen et al., 2007). However, CS-IONP clusters can
be seen in Figure 1, since CS-IONPs were not dispersed
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Figure 1. Inverted microscope images of control cells and PAA- and CS-IONP-treated SaOs-2 cells. Arrows show clustered NPs. Scale
bars correspond to 100 µm.
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well in cell culture media. CS has a cationic structure due
to its amino groups (Fang and Zhang, 2009; Coelho et al.,
2010; Kim, 2013), and a hydrogen bond occurs between
the hydrogen in the amino group and oxygen in Fe3O4
(Hong et al., 2010). The –OH groups that remain unbound
and give CS its typical cationic nature are expected to act
as a means for IONPs to repel each other, and prevent
agglomeration. However, in this case, this positive charge
was possibly hindered by the ionic microenvironment of
the culture medium and could not prevent agglomeration
(Hussain et al., 2009).
3.2. Cell viability
Formazan crystals formed by MTT were dissolved in
DMSO and quantified by measuring the absorbance of
the solution at 570–690 nm. The absorbance values are
proportional to the number of viable cells. Results show that
cytotoxicity of the IONPs is more significant in the culture
medium supplemented with lower serum concentration
(1% FBS) (Figure 2). SaOs-2 cell viability was lower than
that of the control at all concentrations of PAA-IONPs
and further decreased with increasing amount of PAAIONPs in both serum concentrations, except at 10 µM

on day 3 (Figures 2 and 3). CS-IONPs showed the same
effect as PAA-IONPs; however, especially in the 10% FBSsupplemented medium, the effect did not dramatically
increase with increasing CS-IONP concentration.
PAA-IONPs had a reduced cytotoxic effect compared
to CS-IONPs at a concentration of 10 µM, but higher
concentrations enhanced the decrease in cell viability.
3.3. Cell membrane integrity
Disruption of cell membrane integrity is proportional to
the amount of LDH that leaks from the cytoplasm. Figure
4 shows the effect of nanoparticles on cell membrane
integrity after 24 and 72 h of exposure. As opposed to the
MTT results, PAA-IONPs did not show any significant
LDH leakage at any concentration over 72 h of incubation.
On the contrary, there was an increase in LDH release levels
of CS-IONP groups at both 10 and 100 µM concentrations
at both time points, and this increase was more substantial
at the 1000 µM concentration.
3.4. SEM and EDX analysis
Cell morphology and dispersion of IONPs were analyzed
by SEM (Quanta 250 FEG, FEI, Hillsboro, OR, USA) after
72 h of exposure (Figure 5). Elemental analyses of the
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Figure 2. MTT graphics of SaOs-2 cells in the culture medium
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(10, 100, and 1000 µM): A) day 1, B) day 3. Asterisk indicates
statistically significant differences between the data set and the
control: *P < 0.05, **P < 0.01, ***P < 0.001.
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cell surface and IONPs for both experimental groups are
shown in Figure 6. According to EDX results, bright parts
of the cells indicate IONPs. Spectra 1 and 5, which were
taken from dark regions, have significantly lower amounts
of Fe (0.04% and 0.27% wt., respectively) than spectra 2
and 6 (7.88% and 6.21% wt., respectively), which were
taken from bright regions (Table).
SEM images show that the morphology of the SaOs-2
cells treated with IONPs is not different from that of the
control group. However, CS-IONP clusters and rings are
observed clearly on the cell membranes, especially around
the nucleus.
4. Discussion
The results indicate that, on the IONPs tested, the CS
coating induces a greater cytotoxic effect on SaOs-2 cells
than the PAA coating. As seen in Figures 2 and 3, both
CS and PAA have similar effects on the SaOs-2 cell line:
both coatings decrease cell viability, particularly at lower
serum concentrations, and the increasing concentration of
IONPs decreases cell viability further. However, Figure 4
indicates that coating material is very important for the
preservation of membrane integrity. High amounts of LDH

were released from cells treated with CS-IONPs, while cells
treated with PAA-IONPs were not significantly affected
compared to the control. The effects seem to be through
the inhibition of cell proliferation, rather than decreased
cell viability or disruption of membrane integrity for PAAIONPS, while the CS coating definitely causes disrupted
cell membrane integrity in IONPs. Toxicity levels increased
as the NP concentration increased for both coating types.
It was shown before that increasing IONP concentration
in culture medium results in a decreased cell proliferation
rate (doubling time). Particularly, high levels of IONP
localization around a nucleus diminish the efficiency of
protein expression and hinder actin maturation (Soenen
et al., 2010). Similar localization of IONPs is visible in
this study for 1000 µM CS-IONPs, which also showed
the highest level of toxicity in both MTT and LDH tests.
Although the effect mechanisms of nanoparticles have not
been determined clearly yet, some studies indicate that
NP–cell interaction can be affected via NP–culture media
interaction and properties of NPs can be altered by culture
media composition (Mahmoudi et al., 2010; Mura et al.,
2011).
FBS is used to supplement culture media for in vitro
tests to support cell proliferation and maintenance. Serum
is animal-derived and has variable chemical composition,
in which several proteins, amino acids, growth factors,
trace elements, vitamins, etc. are found (van der Valk et
al., 2010). It has been reported that CS-coated NPs form
a bridge between NPs and cells because plasma proteins
are adsorbed onto NPs (Wang et al., 2011). Several authors
have shown that positively charged serum proteins are
adsorbed on positively charged NPs, which often causes
a shielding or protective effect on cell viability (Nafee
et al., 2009; Schulze et al., 2009). These high-affinity
proteins constitute the first layer of the biocorona, usually
called the “hard corona” (Frohlich et al., 2012; Tenzer
et al., 2013; Au et al., 2016), and this corona basically
determines the binding/internalization, as well as the
following functionality of the NP. The significant cytotoxic
effect of CS-IONPs can be explained by the high proteinabsorbing capacity of CS-coated surfaces, which might
alter the conformation of absorbed proteins and lead to
the disruption of physiological processes (Kim et al., 2013;
Xu et al., 2016).
Although CS is a commonly used biocompatible
polymer, the vast majority of papers testing CS cytotoxicity
are based on cases where CS is not internalized by the
cells. However, as shown in the study by Petri-Fink et al.
(2005), due to the interaction of the amino groups on the
surface of CS with the negatively charged domains on cell
membranes, CS-IONPs pass through the cell membrane.
Cationic NPs were shown to have enhanced cellular
uptake compared to anionic or neutral NPs and to induce
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Figure 5. SEM images of the SaOs-2 cells.

more ROS and mitochondrial and lysosomal damage
(Mahmoudi et al., 2011a; Liu et al., 2013; Calatayud et al.,
2014). They were also shown to cause more disruption
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of plasma membrane integrity and more hole formation,
particularly in nonphagocytic cells (Nafee et al., 2009;
Frohlich, 2012; Carvalho et al., 2016).
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A

A
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B

Figure 6. EDX results of cell surface and IONPs: A) PAA- and B) CS-coated.

CS-IONPs also showed significantly higher LDH
leakage, particularly at 1000 µM, than the PAA-IONPs
and controls. The membrane integrity of the cells treated
with anionic PAA-IONPs was not affected. It has been well
documented in the literature that NPs can cause structural
damage to cells, and the extent of leakage is determined
by the surface chemistry of the NPs (Li and Gu, 2010; Lin
et al., 2010). It has been shown that cationic NPs show
higher cytotoxicity compared to their neutral and anionic
analogues, since they interact electrostatically with the
negatively charged lipid bilayer and depolarize the cell
membrane (Goodman et al., 2004; Calatayud et al., 2014).
Cationic NPs also stimulate the Ca2+ influx through the
membrane (Hwang et al., 2015). This change in membrane
potential and Ca2+ influx enhances the internalization of
NPs with the cost of increased toxicity.

The cytotoxic effect of CS-IONPs in both MTT and
LDH assays can be explained by these phenomena: 1)
cell proliferation could be inhibited or the proliferation
rate could be decreased since the proteins carried inside
the cytoplasm by the aid of the CS coating have altered
conformations that might have detrimental effects on
various physiological processes, and 2) cell membrane
integrity could be disrupted because of the free positive
charge of the CS coating.
The most explicit limitation of working with IONPs
is that there is still no universally accepted method to
investigate the possible cytotoxicity of these materials
because cellular responses can be changed via several
different pathways. Size, chemical structure, and physical and
surface properties, as well as their interactions with culture
media, could easily affect the results. As this paper clearly
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Table. Quantitative results of EDX analysis.
Element

Spectrum 1

Spectrum 2

Spectrum 5

Spectrum 6

Wt.%

Atomic%

Wt.%

Atomic%

Wt.%

Atomic%

Wt.%

Atomic%

C

50.28

61.42

42.28

55.29

42.09

54.16

61.07

47.77

O

33.44

30.67

35.71

35.06

35.81

34.59

29.15

30.38

Na

1.79

1.14

1.44

0.98

2.35

1.58

1.30

1.95

Al

0.77

0.42

0.69

0.40

1.04

0.59

0.43

0.76

Si

10.00

5.22

8.96

5.01

13.51

7.43

9.55

5.22

P

0.00

0.00

0.12

0.06

0.00

0.00

0.15

0.07

K

1.74

0.65

1.51

0.61

2.44

0.97

1.67

0.65

Ca

0.18

0.07

0.17

0.07

0.07

0.03

0.10

0.04

Fe

0.04

0.01

7.88

2.22

0.27

0.07

6.21

1.71

Zn

1.77

0.40

1.24

0.30

2.41

0.57

1.47

0.34

Total

100.00

100.00

100.00

100.00

100.00

100.00

100.00

100.00

indicates, PAA-IONPs do not show statistically significant
cytotoxicity according to LDH results in Figure 2, but it has
also been shown that they could decrease cell proliferation,
even when they are used in lower concentrations (Figure 1).
Using just one method could lead to false negative or false
positive results. Existing methods focused on revealing only
one cellular response remain insufficient for cytotoxicity
evaluation. To overcome this issue, comprehensive studies
have to be carried out with different cell lines and NPs
with a wide range of concentration and sizes. Developing
a standard and universally accepted method may not be
achievable immediately, but consideration of these issues
while working with IONPs could help prevent fluctuation
of results among different groups.

These results emphasize the need for standardized
test methods for preclinical testing of NPs. Biomaterials
that are generally considered safe for clinical use, like
CS, can induce significant cytotoxic effects when used
as NP-coating layers. This fact curtails their potential in
drug delivery systems for regenerative and/or therapeutic
purposes, while it can be exploited as an advantage when
targeting cancerous tissues.
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